Stock Quote Notification for Eli Lilly and Company

Eli Lilly and sent this email to their subscribers on November 22, 2024.

Company: Eli Lilly and Company
Ticker: LLY
Exchange: NYSE
Last Trade: $749.92
Change: -3.49
% Change: -0.46%
Volume: 3,970,435
Day's High: $753.00
Day's Low: $735.00
Previous Close: $753.41

Text-only version of this email

Eli Lilly and Company Company: Eli Lilly and Company Ticker: LLY Exchange: NYSE Last Trade: $749.92 Change: -3.49 % Change: -0.46% Volume: 3,970,435 Day's High: $753.00 Day's Low: $735.00 Previous Close: $753.41

Show all

The Latest Emails Sent By Eli Lilly and

Stock Quote Notification for Eli Lilly and Company

Stock Quote Notification for Eli Lilly and Company

FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease

FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease

Stock Quote Notification for Eli Lilly and Company

Stock Quote Notification for Eli Lilly and Company

New Form 8-K for Eli Lilly and Company

New Form 8-K for Eli Lilly and Company

Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance

Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance

Stock Quote Notification for Eli Lilly and Company

Stock Quote Notification for Eli Lilly and Company